Beta Drugs manufactures a wide range of anti-cancer medications, including various therapeutic classes such as alkylating agents, kinase inhibitors, and microtubule inhibitors.

The company focuses on developing novel drug delivery systems like liposomes and nanoparticles, and has commercialized products like Nanoparticle-Albumin-Bound Paclitaxel.